Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Biochemically Recurrent Prostate Cancer
View Full LandscapeTarget Indication
Biochemically Recurrent Prostate Cancer
Clinical Trial
NCT05526248Last updated: 12/16/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Acute Coronary Syndrome
Overactive Bladder
Pneumonia, Bacterial
Chronic Kidney Disease
Colorectal Neoplasms